Defence Therapeutics (TSE:DTC) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Defence Therapeutics Inc. announces the addition of molecular and antibody research expert Dr. Elias Theodorou to its board of directors, enhancing its scientific expertise. Dr. Theodorou, with over 25 years of experience, will provide guidance for Defence’s development, particularly in the USA. Additionally, the company appointed Mr. Arnab De as CFO and Corporate Secretary.
For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.